544529 — Aptus Pharma Balance Sheet
0.000.00%
- IN₹1.25bn
- IN₹1.31bn
- IN₹465.75m
Annual balance sheet for Aptus Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 5.37 | 9.15 | 52.1 | 10.3 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 28.2 | 39.8 | 74.6 | 206 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 56.5 | 83.2 | 197 | 352 |
| Net Property, Plant And Equipment | 5.14 | 6.17 | 9.63 | 27.1 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 62.2 | 100 | 219 | 435 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 31.3 | 41.4 | 121 | 193 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 52.5 | 82.6 | 150 | 202 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 9.68 | 17.7 | 69.7 | 233 |
| Total Liabilities & Shareholders' Equity | 62.2 | 100 | 219 | 435 |
| Total Common Shares Outstanding |